Inventor · disambiguated record
Yuntao Song
Also filed as: SONG YUNTAO
19 granted patents·11 pending applications·187 citations·filing 1998–2022
93Inventor score
Files withWARNER LAMBERT CO10BEIJING XUANYI PHARMASCIENCES CO LTD7BOLTON GARY L2CS PHARMATECH LTD2MILLENNIUM PHARM INC2
Top patents by PatentIndex Score
30 records- 0192US6458781B1Substituted diarylalkyl amides as calcium channel antagonistsFiled 1999·Granted Oct 1, 2002·68 cites·20 claims
- 0290US6362174B1Reduced dipeptide analogues as calcium channel antagonitstsWARNER LAMBERT CO·Filed 2001·Granted Mar 26, 2002·23 cites·14 claims
- 0376US11485782B2Anti-claudin 18.2 antibodiesBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2019·Granted Nov 1, 2022·2 cites·16 claims
- 0475US7250444B2Pyrrole-based HMG-CoA reductase inhibitorsPFIZER·Filed 2004·Granted Jul 31, 2007·9 cites·34 claims
- 0575US6423689B1Peptidyl calcium channel blockersWARNER LAMBERT CO·Filed 1998·Granted Jul 23, 2002·48 cites·146 claims
- 0673US6323243B1Tyrosine-derived compounds as calcium channel antagonistsWARNER LAMBERT CO·Filed 2000·Granted Nov 27, 2001·6 cites·18 claims
- 0771US8680089B2Fused pyridine derivativesHUANG ZHENHUA·Filed 2011·Granted Mar 25, 2014·2 cites·18 claims
- 0868US7067538B2MCP-1 receptor antagonists and methods of use thereofWARNER LAMBERT CO·Filed 2003·Granted Jun 27, 2006·4 cites·15 claims
- 0965US6951848B2Functionalized heterocycles as modulators of chemokine receptor function and methods of use thereforMILLENNIUM PHARM INC·Filed 2002·Granted Oct 4, 2005·3 cites·36 claims
- 1056US6117841ASubstituted peptidylamine calcium channel blockersWARNER LAMBERT CO·Filed 1998·Granted Sep 12, 2000·20 cites·29 claims
- 1155US12378299B2CD80 variant proteins and uses thereofXUANZHU BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·10 claims
- 1255US2024269293A1Protein-macromolecule conjugates and methods of use thereofBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2022·Application pending·0 cites
- 1349US2005075348A1Functionalized heterocycles as modulators of chemokine receptor function and methods of use thereforMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 1449US2006287378A1Novel pyrroles and imidazolesBOLTON GARY L·Filed 2006·Application pending·0 cites
- 1547US11351170B2Substituted pyrimidines as CDK4/6 inhibitorsBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2018·Granted Jun 7, 2022·0 cites·18 claims
- 1647US6469038B1Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockersWARNER LAMBERT CO·Filed 2000·Granted Oct 22, 2002·0 cites·13 claims
- 1747US2024066133A1Therapeutic agents and conjugates thereofBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2021·Application pending·0 cites
- 1847US2005239857A1Novel imidazolesBOLTON GARY L·Filed 2005·Application pending·0 cites
- 1946US6166052AHeteroaryl alkyl alpha substituted peptidylamine calcium channel blockersWARNER LAMBERT CO·Filed 1999·Granted Dec 26, 2000·2 cites·18 claims
- 2046US2022089636A1Tetrazolone substituted steroids and use thereofBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 2146US2005154042A1N-alkyl pyrroles as HMG-CoA reductase inhibitorsFiled 2004·Application pending·0 cites
- 2244US6989448B2Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockersHU LAIN-YEN·Filed 2002·Granted Jan 24, 2006·0 cites·11 claims
- 2343US2007088069A1Novel imidazolesWARNER LAMBERT CO·Filed 2006·Application pending·0 cites
- 2442US2022401561A1Protein-macromolecule conjugates and methods of use thereofBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2020·Application pending·0 cites
- 2539US11773132B2Cyclic di-nucleotides as stimulator of interferon genes modulatorsBEIJING XUANYI PHARMASCIENCES CO LTD·Filed 2018·Granted Oct 3, 2023·0 cites·15 claims
- 2637US10435388B2Selective inhibitors of clinically important mutants of the EGFR tyrosine kinaseCS PHARMATECH LTD·Filed 2017·Granted Oct 8, 2019·0 cites·24 claims
- 2737US2016214996A1Macrocyclic compounds for the treatment of proliferative diseasesCS PHARMASCIENCES INC·Filed 2016·Application pending·0 cites
- 2836US2020131176A1Selective inhibitors of clinically important mutants of the egfr tyrosine kinaseCS PHARMATECH LTD·Filed 2018·Application pending·0 cites
- 2934US6316440B1Reduced dipeptide analogues as calcium channel antagonistsWARNER LAMBERT CO·Filed 1999·Granted Nov 13, 2001·0 cites·7 claims
- 3030US6180677B1Tyrosine-derived compounds as calcium channel antagonistsWARNER LAMBERT CO·Filed 1999·Granted Jan 30, 2001·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Yuntao Song files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →